• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-B51 对日本白塞病患者临床表现的影响:一项全国性调查。

The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey.

机构信息

Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

出版信息

Mod Rheumatol. 2020 Jul;30(4):708-714. doi: 10.1080/14397595.2019.1649103. Epub 2019 Aug 6.

DOI:10.1080/14397595.2019.1649103
PMID:31386589
Abstract

To scrutinize the influence of HLA-B51 to each clinical manifestation of patients with Behçet's disease (BD) using a database of the Ministry of Health, Labour and Welfare of Japan. The database of newly registered patients with BD was obtained from the Japanese Ministry of Health, Labour and Welfare. Patients who met International Criteria for Behçet's Disease (ICBD) and had data for HLA-B51 were selected and analyzed. Among the 3044 analyzable cases, 1334 (43.8%) were men and 1710 (56.2%) were women; the median age was 38 years (IQR 29-48). HLA-B51 was positive for 1334 (44.5%). Prevalence of selected manifestations was 98.5% for oral ulceration, 85.5% for skin lesion, 42.1% for ocular lesion, 69.1% for genital ulceration, and 29.0% for gastrointestinal symptom. HLA-B51-positive patients had higher risk for ocular lesion (OR 1.59, 95%CI: 1.37-1.84;  < .001) and lower risk for genital ulceration (OR 0.72, 95%CI: 0.62-0.84;  < .001) and gastrointestinal symptom (OR 0.65, 95%CI: 0.55-0.77;  < .001). No significant difference was observed for other organ involvement; oral ulceration, skin lesion, positive pathergy test, arthritis, epididymitis, vascular lesion, or neurological manifestation. Subgroup analyses revealed that HLA-B51 was not related to genital ulceration in the cases with an ICBD score of 6 or higher and that HLA-B51 tended to more largely affect the risk of three manifestations for men compared to that for women. HLA-B51 positive is a risk factor for ocular lesion and vice versa for genital ulceration and gastrointestinal symptoms in patients with Japanese BD.

摘要

利用日本厚生劳动省的数据库,深入研究 HLA-B51 对 Behçet 病(BD)患者各临床表现的影响。该数据库是从日本厚生劳动省新登记的 BD 患者数据库中获得的。选择并分析了符合 Behçet 病国际标准(ICBD)且具有 HLA-B51 数据的患者。在可分析的 3044 例患者中,男性 1334 例(43.8%),女性 1710 例(56.2%);中位年龄为 38 岁(IQR 29-48)。HLA-B51 阳性者 1334 例(44.5%)。口腔溃疡、皮肤损害、眼部病变、生殖器溃疡和胃肠道症状的发生率分别为 98.5%、85.5%、42.1%、69.1%和 29.0%。HLA-B51 阳性患者眼部病变风险较高(OR 1.59,95%CI:1.37-1.84;<0.001),生殖器溃疡(OR 0.72,95%CI:0.62-0.84;<0.001)和胃肠道症状(OR 0.65,95%CI:0.55-0.77;<0.001)的风险较低。其他器官受累、口腔溃疡、皮肤损害、阳性 PAT 试验、关节炎、附睾炎、血管病变或神经表现无显著差异。亚组分析显示,HLA-B51 与 ICBD 评分≥6 分的生殖器溃疡无关,与女性相比,HLA-B51 更倾向于增加男性三种表现的风险。HLA-B51 阳性是日本 BD 患者眼部病变的危险因素,反之则是生殖器溃疡和胃肠道症状的危险因素。

相似文献

1
The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey.HLA-B51 对日本白塞病患者临床表现的影响:一项全国性调查。
Mod Rheumatol. 2020 Jul;30(4):708-714. doi: 10.1080/14397595.2019.1649103. Epub 2019 Aug 6.
2
Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.白塞病的临床表现取决于性别和年龄:来自日本全国登记的数据结果
Rheumatology (Oxford). 2017 Nov 1;56(11):1918-1927. doi: 10.1093/rheumatology/kex285.
3
Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.丝绸之路起点的白塞病:意大利东北部的经验
Acta Dermatovenerol Croat. 2017 Dec;25(4):295-297.
4
Behçet's disease in Iraqi patients.伊拉克患者中的白塞病。
Ann Rheum Dis. 1986 Dec;45(12):987-90. doi: 10.1136/ard.45.12.987.
5
The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.白塞病患者血浆同型半胱氨酸水平与 HLA-B51 的关系:病例对照研究。
Int J Rheum Dis. 2014 May;17(4):466-70. doi: 10.1111/1756-185X.12271. Epub 2014 Jan 16.
6
Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.HLA-B51 或 B5 基因型与白塞病临床特征的关系:观察性研究的系统评价和荟萃分析。
Rheumatology (Oxford). 2012 May;51(5):887-900. doi: 10.1093/rheumatology/ker428. Epub 2012 Jan 11.
7
Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients.突尼斯的白塞病。260例患者的人口统计学、临床和遗传学特征
Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S58-64.
8
The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behçet's disease.白塞病早期眼部受累并不伴有生殖器溃疡或胃肠道症状。
Mod Rheumatol. 2019 Mar;29(2):357-362. doi: 10.1080/14397595.2018.1457424. Epub 2018 May 15.
9
Behcet's disease: from East to West.白塞病:从东到西。
Clin Rheumatol. 2010 Aug;29(8):823-33. doi: 10.1007/s10067-010-1430-6. Epub 2010 Mar 31.
10
HLA-B51 Impact on Clinical Symptoms in Behcet's Disease.HLA-B51 对贝赫切特病临床症状的影响。
J Coll Physicians Surg Pak. 2022 Jul;32(7):904-908. doi: 10.29271/jcpsp.2022.07.904.

引用本文的文献

1
Case Report: Kyrieleis plaques in an unusual Behcet's disease uveitis.病例报告:罕见的白塞病葡萄膜炎中的基里尔艾斯斑。
Front Med (Lausanne). 2025 May 22;12:1544319. doi: 10.3389/fmed.2025.1544319. eCollection 2025.
2
Behçet's disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan.白塞病:日本的发病率、患病率及生物制剂使用的真实世界数据。
J Gastroenterol. 2025 Mar;60(3):294-305. doi: 10.1007/s00535-024-02191-y. Epub 2024 Dec 6.
3
Behçet's Disease: A Comprehensive Review on the Role of , Antigen Presentation, and Inflammatory Cascade.
贝赫切特病: 对 、抗原呈递和炎症级联作用的全面综述。
Int J Mol Sci. 2023 Nov 16;24(22):16382. doi: 10.3390/ijms242216382.
4
Epidemiologic and Etiological Features of Korean Patients With Behçet's Disease.韩国白塞病患者的流行病学和病因学特征
J Rheum Dis. 2021 Oct 1;28(4):183-191. doi: 10.4078/jrd.2021.28.4.183.
5
[Analysis of clinical diagnosis and treatment of Behet's disease with sore throat as the first symptom].以咽痛为首发症状的白塞病临床诊治分析
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Feb;37(2):127-132. doi: 10.13201/j.issn.2096-7993.2023.02.010.
6
The association of Behçet's syndrome with HLA-B51 as understood in 2021.2021 年对 Behçet 综合征与 HLA-B51 关联性的认识。
Curr Opin Rheumatol. 2022 Jan 1;34(1):4-9. doi: 10.1097/BOR.0000000000000846.
7
Behçet syndrome.白塞综合征。
Nat Rev Dis Primers. 2021 Sep 16;7(1):67. doi: 10.1038/s41572-021-00301-1.
8
A Contemporary Review of Behcet's Syndrome.《贝赫切特综合征的当代综述》。
Clin Rev Allergy Immunol. 2021 Dec;61(3):363-376. doi: 10.1007/s12016-021-08864-3. Epub 2021 Jun 2.
9
Current research status of HLA in immune-related diseases.免疫相关性疾病中 HLA 的研究现状。
Immun Inflamm Dis. 2021 Jun;9(2):340-350. doi: 10.1002/iid3.416. Epub 2021 Mar 3.
10
Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan.临床聚类比例的变化促成了日本白塞病的表型演变。
Arthritis Res Ther. 2021 Feb 1;23(1):49. doi: 10.1186/s13075-020-02406-6.